Background: Depilatory radiotherapy for ringworm was largely used before antifungals were available. Patients who underwent this treatment are at high risk of developing scalp tumors or other cancers. The aim of this study was to characterize scalp tumors occurring after X-ray therapy for ringworm. Methods: We included cases of postradiotherapy scalp tumors recorded at the Dermatology Department of the Charles Nicolle Hospital, Tunis between 1988 and 2001. We recorded clinical descriptions and all cases were resubmitted to microscopic analysis. Results: Sixty-one tumors occurred in 33 men and 12 women with a mean age of 49.8 years. Radiodermatitis was present in 21% of patients. Tumors were basal cell carcinomas in 47 cases, trichoblastomas in 10 cases and trichoblastic carcinomas in 4 cases. Twelve patients had 2–5 tumors, with combinations of tumor types in 3 of them. Mean delay of onset of tumors after radiotherapy was 39.4 years in basal cell carcinoma cases, 38.3 years in trichoblastoma cases and 35.6 years in trichoblastic carcinoma cases. Conclusions: This series shows that although basal cell carcinoma is the most frequent tumor in this situation, trichoblastomas are common. We describe, for the first time, radio-induced trichoblastic carcinomas. Trichoblastic tumors have not yet been described in this context because this concept is relatively recent.

Keywords:
Basal cell carcinoma, Trichoblastoma, Trichoblastic carcinoma, X-ray therapy, Ringworm, Radiodermatitis
1.
Adamson HG: A simplified method of X-ray application for the cure of ringworm of the scalp: Kienbock’s method. Lancet 1909;i: 1378–1380.
2.
Coutelin F, Cochet G, Biquet J, Mallet S, Doby-Dubois M, Deblock S: Contribution à la connaissance épidémiologique et mycologique des teignes infantiles de Tunisie. Ann Parasitol 1956;31:449–469.
3.
Juminer B, Stefanovic M: Evolution des mycoses superficielles en Tunisie. Arch Inst Pasteur Tunis 1963;40:115–123.
4.
Albert RE, Omran AR: Follow-up of patients treated by X-ray epilation for tinea capitis. Arch Environ Health 1968;17:899.
5.
Shore RE, Albert RE, Pasternack BS: Follow up study of patients treated by X-ray epilation for tinea capitis. Arch Environ Health 1976;31:17–24.
6.
Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS: Skin cancer after X-ray treatment for scalp ringworm. Radiat Res 2002;157:410–418.
7.
McKee P, Calonje E, Granter SR: Pathology of the Skin. Philadelphia, Elsevier Mosby, 2005, p 2112.
8.
Ackerman AB, Reddy VB, Soyer HP: Neoplasms with follicular differentiation. New York, Ardor Scribendi, 2001, p 1109.
9.
Carcinome basocellulaire: recommandations pour la pratique clinique (ANAES 2004). Ann Dermatol Venereol 2004;131:680–756.
10.
Rofagha R, Usmani AS, Vadmal M, Hessel AB, Pelligrini AE: Trichoblastic carcinoma: a report of two cases of a deeply infiltrative trichoblastic neoplasm. Dermatol Surg 2001;27:663–666.
11.
Regauer S, Beham-Schmid C, Okcu M, Hartner E, Mannweiler S: Trichoblastic carcinoma (‘malignant trichoblastoma’) with lymphatic and hematogenous metastases. Mod Pathol 2000;13:673–678.
12.
Schultz T, Proske S, Hartschuh W, Karzen H, Paul E, Wunsch PH: High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread. Am J Dermatopathol 2005;27:9–16.
13.
Modan B, Baidatz D, Mart H, Steinitz R, Levin SG: Radiation-induced head and neck tumours. Lancet 1974;23:277–279.
14.
Modan B, Chetrit A, Alfandary E, Tamir A, Lusky A, Wolf M, Shpilberg O: Increased risk of salivary gland tumors after low-dose irradiation. Laryngoscope 1998;108:1095–1097.
15.
Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM: Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996;88:1848–1853.
16.
Ben Hamla A, Joudar S: La dégénérescence maligne des radiodermites du cuir chevelu après radiothérapie pour teigne: a propos de dix lésions. Ann Chir Plast Esthet 1985;30:335–337.
17.
Ridley CM: Basal cell carcinoma following X-ray epilation of the scalp. Br J Dermatol 1962;74:222–223.
18.
Maalej M, Frikha H, Kochbati L, Bouaouina N, Sellami D, Benna F, et al: Radio-induced malignancies of the scalp about 98 patients with 150 lesions and literature review. Cancer Radiother 2004;8:81–87.
19.
Pousti A: Malignant tumours of the scalp resulting from X-ray treatment for tinea capitis. Br J Plast Surg 1979;32:52–54.
20.
Zahaf A, Mkaouar M, Charfi CH, Rebei S: Epithéliomas du cuir chevelu secondaires à une radiothérapie pour teigne (à propos de 12 cas). Nouv Dermatol 1988;7:359–361.
21.
Gabillot-Caré M, Weill F, Mamelle G, Kolb F, Petrow P, Ortoli JC, et al: Microcystic adnexal carcinoma: report of seven cases including one with lung metastasis. Dermatology 2006;212:221–228.
22.
Aszterbaum M, Epstein J, Oro A, Douglas V, Leboit PE, Scott MP, Epstein EH Jr: Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999;11:1285–1291.
23.
Richardson DB, Wing S, Hoffmann W: Cancer risk from low-level ionizing radiation: the role of age at exposure. Occup Med 2001;16:191–218.
24.
Scrivener Y, Grosshans E, Cribier B: Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:41–47.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.